Experts call for coordinated global action to make the most of Alzheimer’s treatments

The approval of new antibody medications for Alzheimer’s disease – lecanemab and donanemab – and diagnostic tests in the blood mark the beginning of a new era in Alzheimer’s disease diagnosis and treatment.